ShareX launches TreasureX Season 2 with a $1 million prize pool
Foresight News reports that the Web3 sharing economy network ShareX has launched its growth campaign TreasureX Season 2, partnering with more than 10 global sharing economy brands to establish a reward pool valued at $1 million. This reward pool includes tokens, USDT, and various Web2 brand rewards, aiming to promote the integration of Web3 technology with real business scenarios.
Currently, TreasureX Season 2 has entered its second phase, "Expansion — The Hunt Unfolds," and has launched a social task module called "Frontier Signals." According to the rules, users who post relevant content on the X platform can earn TreasureXP and have the chance to win an exclusive $10,000 prize pool.
ShareX stated that previously, TreasureX Season 1 attracted more than 870,000 users to participate. TreasureXP will serve as a record of users' real actions and will be linked to future token airdrop allocations, thereby reinforcing the concept of "behavior as asset."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
